Bill restricts U.S. investment in Chinese military tech, forcing pension funds to divest.
S. 1359 — STOP CCP Act of 2025 · Filed by Rick Scott (R-FL) · 2 cosponsors · Introduced Apr 8, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill prohibits U.S. persons (individuals and companies) from buying, selling, or trading securities issued by Chinese companies that operate in defense, surveillance technology, or military-industrial sectors. It also directs the Treasury Department to expand the list of Chinese military-industrial companies subject to sanctions and requires that if sanctions are imposed on a Chinese entity under any law, they must be imposed under all applicable laws unless the President waives them for national security reasons.
Why we flagged it
The bill's core mechanism is a securities investment prohibition targeting Chinese military-industrial and surveillance sectors, coupled with mandatory sanctions expansion. It is framed as a national security measure, not a trade or economic policy bill, and operates through capital-flow restriction rather than tariffs or subsidies.
What the text implies
- The definition of 'Chinese entity' includes any entity 'subject to the jurisdiction' of the PRC government, which is extremely broad and could capture foreign subsidiaries, joint ventures, or companies with Chinese government contracts, creating compliance ambiguity for U.S. investors.
- The phrase 'defense and related materiel sector' is undefined and left to Treasury/State/Defense discretion, giving executive agencies unilateral power to designate companies without clear statutory criteria, potentially enabling political or strategic targeting beyond genuine military-industrial concerns.
The full analysis lists 5 implications of this text.
Who stands to gain
U.S. defense contractors (potential reduced competition from Chinese military-industrial suppliers); U.S. financial advisors and asset managers (increased compliance and portfolio-rebalancing fees); Alternative investment platforms (potential shift of capital from Chinese equities to other markets)